North America Cartilage Degeneration Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Procedure Type (Osteochondral Transplant, Chondroplasty, Joint Replacement, Meniscus Transplants, Cell-based Cartilage Resurfacing, and Others); Application (Knee, Hips and Others); and End User (Hospitals & Specialty Clinics, Ambulatory Surgical Centers and Academic & Research Institutes) and Country
Market Introduction
Degeneration of cartilage leads to pain and chronic inflammation in joints of a human body. Furthermore, damaged cartilage can potentially influence the quality of a patient’s life. Continuous research and developments are innovating new techniques and methodologies to deal with damaged cartilages. A few of these techniques comprise joint replacement, cell therapies, and chondroplasty.
Get more information on this report :
Market Overview and Dynamics
The North America cartilage degeneration market is expected to reach US$ 6,998.45 million by 2027 from US$ 4,889.27 million in 2019; it is anticipated to grow at a CAGR of 4.7% from 2020 to 2027. The increasing prevalence of sports injuries and obesity is expected to boost the growth of the cartilage degeneration market in North America. However, the market is impacted by the high cost of cartilage therapies.
Key Market Segments
In terms of procedure type, the joint replacement segment accounted for the largest share of the North America cartilage degeneration market in 2019. In terms of application, the knee segment accounted for the largest share of the North America cartilage degeneration market in 2019. In terms of end user, the hospitals & specialty clinics segment accounted for the largest share of the North America cartilage degeneration market in 2019.
Major Sources and Companies Listed
Major primary and secondary sources associated with the North America cartilage degeneration market report are the World Health Organization (WHO), American Academy of Orthopaedic Surgeons (AAOS), Washington University Orthopedics, Agency for Healthcare Research and Quality, Centers of Disease Control and Prevention (CDC), National Federation of State High School Associations (NFHS), Arthritis Foundation 2020, and others.
Reasons to buy report
- Understand the Northe America cartilage degeneration market landscape and identify cartilage degeneration segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape in the region
- Efficiently plan mergers and acquisitions, and partnership deals in the North America cartilage degeneration market by identifying segments with the most promising probable sales
- Take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments
- Obtain revenue forecast of market based on various segments for the period 2019–2027.
North America cartilage degeneration market segmentation
By Procedure Type
- Joint Replacement
- Chondroplasty
- Cell-based Cartilage Resurfacing
- Osteochondral Transplant
- Meniscus Transplants
- Others
By Application
- Knee
- Hips
- Others
By End User
- Hospitals & Specialty Clinics
- Ambulatory Surgical Centers
- Academic & Research Institutes
By Country
- US
- Canada
- Mexico
Company Profiles
- Zimmer Biomet
- Stryker Corporation
- Johnson and Johnson Services, Inc.
- CONMED Corporation
- Arthrex, Inc.
- Anika Therapeutics, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Cartilage Degeneration Market – By Procedure Type
1.3.2 North America Cartilage Degeneration Market – By Application
1.3.3 North America Cartilage Degeneration Market– By End User
1.3.4 North America Cartilage Degeneration Market – By Country
2. North America Cartilage Degeneration Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Cartilage Degeneration Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cartilage Degeneration Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Cartilage Degeneration Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Number of Sports Injuries
5.1.2 Increasing Prevalence of Obesity
5.2 Key Market Restraints
5.2.1 High Cost of Cartilage Repair Therapies
5.3 Key Market Opportunities
5.3.1 Growing Number of Product Approvals and Developments
5.4 Future Trends
5.4.1 Rising Emphasis on Regenerative Medicines
5.5 Impact analysis
6. Cartilage Degeneration Market – North America Analysis
6.1 North America Cartilage Degeneration Market Revenue Forecasts and Analysis
7. North America Cartilage Degeneration Market Analysis and Forecasts To 2027 – By Procedure Type
7.1 Overview
7.2 North America Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)
7.2.1 North America Cartilage Degeneration Market Revenue and Forecasts to 2027, By Procedure Type (US$ Mn)
7.3 Osteochondral Transplant
7.3.1 Overview
7.3.2 North America Osteochondral Transplant Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Chondroplasty
7.4.1 Overview
7.4.2 North America Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Joint Replacement
7.5.1 Overview
7.5.2 North America Joint Replacement Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Meniscus Transplants
7.6.1 Overview
7.6.2 North America Meniscus Transplants Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Cell-based Cartilage Resurfacing
7.7.1 Overview
7.7.2 North America Cell-based Cartilage Resurfacing Market Revenue and Forecast to 2027 (US$ Mn)
7.8 Other Procedures
7.8.1 Overview
7.8.2 North America Other Procedures Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Cartilage Degeneration Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 North America Cartilage Degeneration Market, By Application 2019 & 2027 (%)
8.2.1 North America Cartilage Degeneration Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Knee
8.3.1 Overview
8.3.2 North America Knee Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Hip
8.4.1 Overview
8.4.2 North America Hip Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Other Applications
8.5.1 Overview
8.5.2 North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Cartilage Degeneration Market Analysis – By End-User
9.1 Overview
9.2 North America Cartilage Degeneration Market, By End-User 2019-2027 (%)
9.2.1 North America Cartilage Degeneration Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Hospitals and Specialty Centres
9.3.1 Overview
9.3.2 North America Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Ambulatory Surgical Centres
9.4.1 Overview
9.4.2 North America Ambulatory Surgical Centres Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 North America Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
10. Cartilage degeneration Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Cartilage degeneration Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Cartilage Degeneration Market, by Procedure Type, 2018–2027 (USD Million)
10.1.4 North America: Cartilage Degeneration Market, by Application, 2018–2027 (USD Million)
10.1.5 North America: Cartilage Degeneration Market, by End User, 2018–2027 (USD Million)
10.1.6 North America: Cartilage Degeneration Market, by Country, 2019& 2027 (%)
10.1.7 US: Cartilage Degeneration Market– Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Cartilage Degeneration Market, by Procedure Type, 2018–2027 (USD Million)
10.1.7.3 US: Cartilage Degeneration Market, by Application, 2018–2027 (USD Million)
10.1.7.4 US: Cartilage Degeneration Market, by End User, 2018–2027 (USD Million)
10.1.8 Canada: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Cartilage Degeneration Market, by Procedure Type, 2018–2027 (USD Million)
10.1.8.3 Canada: Cartilage Degeneration Market, by Application, 2018–2027 (USD Million)
10.1.8.4 Canada: Cartilage Degeneration Market, by End User, 2018–2027 (USD Million)
10.1.9 Mexico: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
10.1.9.3 Mexico Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
10.1.9.4 Mexico Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Cartilage degeneration Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 Zimmer Biomet
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Stryker Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Johnson and Johnson Services, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 CONMED Corporation
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Anika Therapeutics, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Arthrex, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Cartilage Degeneration Market Revenue and Forecasts To 2027, By Procedure Type (US$ Mn)
Table 2. North America Cartilage Degeneration Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Cartilage Degeneration Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 4. North America Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Cartilage Degeneration Market, by Application, – Revenue and Forecast to 2027 (USD Million)
Table 6. North America Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 7. US Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 8. US Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 9. US Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Cartilage Degeneration Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Cartilage Degeneration Market, by Procedure Type – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Cartilage Degeneration Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Cartilage Degeneration Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. Glossary of Terms, Cartilage Degeneration Market
LIST OF FIGURES
Figure 1. Cartilage Degeneration Market Segmentation
Figure 2. North America Cartilage Degeneration Market Overview
Figure 3. Knee Segment Held Largest Share of Cartilage Degeneration Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Cartilage Degeneration Market - Leading Country Markets (US$ Mn)
Figure 6. Cartilage Degeneration Market - North America PEST Analysis
Figure 7. Cartilage Degeneration Market Impact Analysis of Driver and Restraints
Figure 8. North America Cartilage degeneration Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Cartilage Degeneration Market, By Procedure Type 2019 & 2027 (%)
Figure 10. North America Osteochondral Transplant Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Chondroplasty Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Joint Replacement Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Meniscus Transplants Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Cell-based Cartilage Resurfacing Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Other Procedures Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. North America Cartilage Degeneration Market, By Application 2019 & 2027 (%)
Figure 17. North America Knee Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Hip Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Other Applications Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Cartilage Degeneration Market, by End-User 2019 & 2027 (%)
Figure 21. North America Hospitals and Specialty Centres Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Homecare Settings Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. North America Academic and Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America: Cartilage Degeneration Market, by Key Country – Revenue (2019) (USD Million)
Figure 25. North America Cartilage Degeneration Market Revenue and Forecast to 2027 (USD Million)
Figure 26. North America: Cartilage Degeneration Market, by Country, 2019 & 2027 (%)
Figure 27. US: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 28. Canada: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 29. Mexico: Cartilage Degeneration Market – Revenue and Forecast to 2027 (USD Million)
Figure 30. Impact of COVID-19 Pandemic in North American Country Markets
The List of Companies - North America Cartilage Degeneration Market
- Zimmer Biomet
- Stryker Corporation
- Johnson and Johnson Services, Inc.
- CONMED Corporation
- Arthrex, Inc.
- Anika Therapeutics, Inc.
- Understand the Northe America cartilage degeneration market landscape and identify cartilage degeneration segments that are most likely to guarantee a strong return.
- Stay ahead of the race by comprehending the ever-changing competitive landscape in the region.
- Efficiently plan mergers and acquisitions, and partnership deals in the North America cartilage degeneration market by identifying segments with the most promising probable sales.
- Take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments.
- Obtain revenue forecast of market based on various segments for the period 2019–2027.